Abstract: Antibodies that can specially bind to cytochrome P450 CYP1B1 and methods of making them are disclosed, in particular antibodies that bind to amino acid sequence VNQWSVNHDPVKWPN or PExFDPARFLDKDGy, where x is D or N and y is L or F, or an antigenic fragment thereof. The antibodies can be used in the diagnosis or treatment of cancers linked to enhanced CYP1B1 expression, including breast cancer, prostate cancer, colorectal cancer, liver cancer and ovarian cancer.
Type:
Grant
Filed:
March 20, 2000
Date of Patent:
September 2, 2008
Assignee:
University Court of the University of Aberdeen
Abstract: A method and apparatus for substance monitoring. One application is an easy to handle continuous glucose monitor using a group of hollow out-of-plane silicon microneedles to sample substances in interstitial fluid from the epidermal skin layer. The glucose of the interstitial fluid permeates a dialysis membrane and reaches a sensor. Using MEMS technology, for example, allows well-established batch fabrication at low cost.
Type:
Grant
Filed:
April 19, 2004
Date of Patent:
August 19, 2008
Assignee:
The Regents of the University of California
Inventors:
Stefan Zimmermann, Boris Stoeber, Dorian Liepmann, Albert Pisano
Abstract: The present invention provides safety confirmation or hazard warning to a technician in the field, e.g., by scanning an equipment identification label and comparing the identification to a schedule of equipment inactivation times. The systems and methods of the invention can optionally provide remote interactions to reschedule inactivations or to protect the technician by lock-out from a hazardous condition.
Abstract: Taste receptor polycystin-2L1 is provided. Methods and systems for screening for tastants and receptor modulators are provided. Knock out and transgenic animals, methods of detecting polymorphisms, and methods of correcting taste defects are also provided.
Type:
Grant
Filed:
July 6, 2005
Date of Patent:
August 5, 2008
Assignee:
The Regents of the University of California
Abstract: A test method allows testing of source-synchronous high-speed wide busses on automatic testing equipment for at-speed characterization and production at-speed testing. An integrated circuit that is verified using the method and systems including such an integrated circuit are also disclosed. The invention can enable sampling or testing of signals or test pins that that are running very fast, particular compared to available automatic testing equipment for testing these device. The invention uses data recovery emulation on various types of automated test equipment to capture output data for further, more sophisticated analysis.
Abstract: Translation systems and other compositions including orthogonal aminoacyl tRNA-synthetases that preferentially charge an orthogonal tRNA with an iodinated or brominated amino acid are provided. Nucleic acids encoding such synthetases are also described, as are methods and kits for producing proteins including heavy atom-containing amino acids, e.g., brominated or iodinated amino acids. Methods of determining the structure of a protein, e.g., a protein into which a heavy atom has been site-specifically incorporated through use of an orthogonal tRNA/aminoacyl tRNA-synthetase pair, are also described.
Type:
Grant
Filed:
May 24, 2005
Date of Patent:
July 15, 2008
Assignee:
The Scripps Research Institute
Inventors:
Jianming Xie, Lei Wang, Ning Wu, Peter G. Schultz
Abstract: Provided are fluorescent substrates for ?-lactamases having the general formula I: in which R is a benzyl, 2-thienylmethyl, or cyanomethyl group; R? is selected from the group consisting of H, physiologically acceptable salts or metal, ester groups, ammonium cations, —CHR2OCO(CH2)nCH3, —CHR2OCOC(CH3)3, acylthiomethyl, acyloxy-alpha-benzyl, deltabutyrolactonyl, methoxycarbonyloxymethyl, phenyl, methylsulphinylmethyl, ?-morpholinoethyl, dialkylaminoethyl, and dialkylaminocarbonyloxymethyl, in which R2 is selected from the group consisting of H and lower alkyl; A is selected from the group consisting of S, O, SO, SO2 and CH2; and Z is a donor fluorescent moiety. Also provided are methods of use of the compound of general formula I.
Type:
Grant
Filed:
January 11, 2002
Date of Patent:
July 8, 2008
Assignee:
The Regents of the University of California
Abstract: A humanized murine antibody is provided that binds to the human insulin receptor (HIR). The humanized murine antibody is suitable for use as a Trojan horse to deliver pharmaceutical agents to human organs and tissue that express the HIR. The humanized munne antibody is especially well suited for delivering neuropharmaceutical agents from the blood stream to the brain across the blood brain barrier (BBB). The humanized murine antibody may be genetically fused to the pharmaceutical agent or it may be linked to the pharmaceutical agent using an avidin-biotin conjugation system.
Type:
Grant
Filed:
November 27, 2002
Date of Patent:
June 17, 2008
Assignee:
The Regents of the University of California
Abstract: This invention provides methods and compositions to preserve bioactive materials in a dried foam matrix. Methods provide non-boiling foam generation and penetration of preservative agents at temperatures near the phase transition temperature of the membranes.
Abstract: Methods and compositions for making glycoproteins, both in vitro and in vivo, are provided. One method involves incorporating an unnatural amino acid having a N-acetylgalactosamine moiety into a protein; optionally, the N-acetylgalactosamine-containing unnatural amino acid can be further modified with additional sugars.
Type:
Grant
Filed:
October 20, 2005
Date of Patent:
May 27, 2008
Assignee:
The Scripps Research Institute
Inventors:
Peter G. Schultz, Sarah R. Hanson, Ran Xu, Zhiwen Zhang, Chi-Heuy Wong
Abstract: This invention provides compositions and methods providing, e.g., stable powder particles containing bioactive materials. The methods include, e.g., high pressure spraying of the bioactive materials in solution or suspension, with viscosity enhancing agents and/or surfactants. Compositions of the invention provide, e.g., high initial purity, high stability in storage, and reconstitution at high concentrations.
Abstract: The invention provides methods and compositions for in vivo incorporation of unnatural amino acids. Also provided are compositions including proteins with unnatural amino acids.
Type:
Grant
Filed:
October 18, 2005
Date of Patent:
May 6, 2008
Assignees:
The Scripps Research Institute, The Regents of the University of California
Inventors:
Peter Schultz, Lei Wang, John Christopher Anderson, Jason W. Chin, David R. Liu, Thomas J. Magliery, Eric Meggers, Ryan Aaron Mehl, Miro Pastrnak, Steven William Santoro, Zhiwen Zhang
Abstract: This invention utilizes a two-hybrid system to screen for agents that modulate the ability of a cell to degrade or to accumulate a metabolic product or to selective kill a cell or to selectively express a gene or cDNA in a cell that has a defect in its ability to degrade or to accumulate a metabolic product. One embodiment provides a mammalian cell comprising a nucleic acid encoding a peptide binding domain and an effector gene; a first chimeric protein comprising a nucleic acid binding domain that binds the peptide binding domain attached to the metabolic product or to a ligand that binds to the metabolic product; and a second chimeric protein comprising an expression control protein attached to the metabolic product or to the ligand that binds to the metabolic product such that when the first chimeric protein comprises the metabolic product, the second chimeric protein comprises the ligand and when the first chimeric protein comprises the ligand, the second chimeric protein comprises the metabolic product.
Type:
Grant
Filed:
July 21, 2004
Date of Patent:
April 15, 2008
Assignee:
The Regents of the University of California
Inventors:
Osamu Tetsu, Kenichi Wakita, Frank McCormick
Abstract: This invention provides compositions and methods for generating components of protein biosynthetic machinery including orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases, and orthogonal pairs of tRNAs/synthetases. Methods for identifying orthogonal pairs are also provided. These components can be used to incorporate unnatural amino acids into proteins in vivo.
Type:
Grant
Filed:
October 18, 2005
Date of Patent:
April 8, 2008
Assignees:
The Scripps Research Institute, The Regents of the University of California
Inventors:
Peter G. Schultz, Lei Wang, John Christopher Anderson, Jason Chin, David R. Liu, Thomas J. Magliery, Eric L. Meggers, Ryan Aaron Mehl, Miro Pastrnak, Steven William Santoro, Zhiwen Zhang
Abstract: This invention provides novel fuel cell catalysts comprising new series of catalytically active thin-film metal alloys with low platinum concentration supported on nanostructured materials (nanoparticles). In certain embodiments, an integrated gas-diffusion/electrode/catalyst layer can be prepared by processing catalyst thin films and nanoparticales into gas-diffusion media such as Toray or SGL carbon fiber papers. The catalysts can be placed in contact with an electrolyte membrane for PEM fuel cell applications.
Abstract: A cell-free method for translation and assembly of retroviral, particularly HIV, capsid and capsid intermediates is disclosed. Also disclosed are novel HIV capsid assembly intermediates and novel host proteins which bind to such assembly intermediates. The invention also includes a screening method for compounds that alter retrovirus capsid assembly, and a method of treating HIV using compounds which inhibit the HIV capsid assembly pathway.
Type:
Grant
Filed:
January 17, 2003
Date of Patent:
March 25, 2008
Assignee:
The Regents of the University of California
Inventors:
Jaisri R. Lingappa, Vishwanath R. Lingappa
Abstract: This invention provides methods, NMR probes, and NMR systems for the analysis of the contents of sealed food and beverage containers and the like.
Type:
Grant
Filed:
March 10, 2006
Date of Patent:
March 4, 2008
Assignee:
The Regents of the University of California
Inventors:
Matthew P. Augustine, April J. Weekley, Paul Bruins
Abstract: A derailler with a set of gears powered by bicycle chain to drive an AC generator. A bridge rectifier to convert AC to DC to charge the battery and to energize the head light and the tail light. A set of switches to control the head light, tail light, and battery.
Abstract: An in vitro method for identifying subjects at risk of heart failure following a Myocardial Infarction comprising analyzing the concentration of Matrix Metalloproteinase-9 in a bodily sample from a subject who has suffered a Myocardial Infarction and comparing this concentration with a reference for concentrations of Matrix Metalloproteinase-9 in individuals who have not suffered a Myocardial Infarction; wherein a raised concentration of Matrix Metalloproteinase-9 in the bodily sample from a subject who has suffered a Myocardial Infarction suggests the subject is at risk of heart failure.
Abstract: Methods of detecting components of interest, e.g., nucleic acids and sugars, are provided. The methods comprise contacting one or more nanowires comprising a functional group with a sample containing the component or components of interest. In one embodiment, the functional group comprises a hairpin oligonucleotide, e.g., a hairpin that changes conformation upon binding the component of interest, e.g., a nucleic acid. The change in conformation produces a change in charge that is detected. In another embodiment, the functional group comprises an enzyme, e.g., glucose oxidase, which produces a change in pH when glucose is present in a sample.
Type:
Grant
Filed:
October 9, 2003
Date of Patent:
December 4, 2007
Assignee:
Nanosys, Inc.
Inventors:
Larry Bock, R. Hugh Daniels, Stephen Empedocles